Genetic Disease Diagnostic Market Size, Share, Trends, Growth Outlook

Genetic Disease Diagnostic Market is estimated to increase at a growth rate of 9.1% CAGR over the forecast period from 2024 to 2030.

The Genetic Disease Diagnostic Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Application (Inherited Disorder Testing, PharmacoBy (PGx), Human Leukocyte Antigen (HLA) Testing, Oncology Testing, Others).

An Introduction to Genetic Disease Diagnostic Market in 2024

The Genetic Disease Diagnostic market in 2024 addresses the demand for diagnostic tests and genetic screening services aimed at identifying and characterizing genetic abnormalities, mutations, and chromosomal disorders associated with inherited diseases and congenital disorders. Genetic disease diagnostics encompass a range of tests such as karyotyping, fluorescence in situ hybridization (FISH), chromosomal microarray analysis (CMA), and DNA sequencing, enabling the detection of genetic variations and molecular markers linked to genetic conditions such as cystic fibrosis, sickle cell disease, Huntington's disease, and Down syndrome. Market dynamics are driven by factors such as the increasing prevalence of genetic disorders, advancements in molecular genetics and genomic technologies, and the demand for early and accurate diagnosis of genetic diseases for prenatal screening, newborn screening, and carrier testing purposes. Collaboration between genetic testing laboratories, medical geneticists, and genetic counselors drives innovation and market growth in genetic disease diagnostics, supporting improved genetic counseling, family planning, and disease management strategies for individuals and families affected by genetic conditions.

Genetic Disease Diagnostic Market Trend: Integration of Next-Generation Sequencing (NGS) in Genetic Disease Diagnosis

A prominent trend in the genetic disease diagnostic market is the integration of next-generation sequencing (NGS) technologies. NGS has revolutionized genetic testing by enabling rapid and comprehensive analysis of DNA, RNA, and other genetic materials. This trend encompasses the adoption of NGS panels and whole exome or genome sequencing for diagnosing a wide range of genetic diseases, including rare and complex disorders. The increased throughput, accuracy, and cost-effectiveness of NGS platforms have accelerated the diagnosis of genetic diseases, driving demand for genetic testing services that leverage these advanced sequencing technologies to provide accurate and timely diagnostic insights to patients and healthcare providers.

Genetic Disease Diagnostic Market Driver: Growing Demand for Early and Accurate Diagnosis of Genetic Disorders

A key driver in the genetic disease diagnostic market is the growing demand for early and accurate diagnosis of genetic disorders. Genetic diseases encompass a broad spectrum of inherited disorders, ranging from single-gene mutations to complex chromosomal abnormalities, and can manifest at any stage of life. Early diagnosis is crucial for timely intervention, personalized treatment planning, and disease management, particularly in pediatric populations where early detection can lead to better clinical outcomes and improved quality of life. This driver is fueled by factors such as advancements in genetic testing technologies, increasing awareness of genetic diseases among healthcare professionals and patients, and expanding access to genetic testing services globally, driving market growth and innovation in genetic disease diagnostics.

Genetic Disease Diagnostic Market Opportunity: Development of Point-of-Care Genetic Testing Solutions

An opportunity for growth in the genetic disease diagnostic market lies in the development of point-of-care (POC) genetic testing solutions. POC testing offers the advantages of rapid turnaround time, ease of use, and accessibility, enabling genetic testing to be performed at the bedside or in community healthcare settings without the need for specialized laboratory infrastructure. By developing POC genetic testing devices and assays, manufacturers can address the unmet needs for timely and accessible genetic diagnostics, particularly in resource-limited settings and underserved populations. This opportunity requires a focus on miniaturization, automation, and user-friendly design to enable efficient and accurate genetic testing outside of traditional laboratory settings, facilitating early diagnosis and personalized management of genetic diseases in diverse healthcare settings.

Genetic Disease Diagnostic Market Segmentation

By Applications
Inherited Disorder Testing
-Bloom Syndrome
-Gaucher’s Disease
-Tay-Sachs Disease
-Fragile X-Syndrome
-Others
PharmacoBy (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Genetic Disease Diagnostic Market Companies

Abbott Inc
Applied Biosystems Inc
AutoGenomics
BioRad Laboratories
Celera Group
Elitech Group
PerkinElmer Inc
Quest Diagnostics
Roche Diagnostics Corp
Transgenomic Inc

 

 

Reasons to Buy the Genetic Disease Diagnostic Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Genetic Disease Diagnostic Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Genetic Disease Diagnostic Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Genetic Disease Diagnostic Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Genetic Disease Diagnostic Market Size Outlook, $ Million, 2021 to 2030
3.2 Genetic Disease Diagnostic Market Outlook by Type, $ Million, 2021 to 2030
3.3 Genetic Disease Diagnostic Market Outlook by Product, $ Million, 2021 to 2030
3.4 Genetic Disease Diagnostic Market Outlook by Application, $ Million, 2021 to 2030
3.5 Genetic Disease Diagnostic Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Genetic Disease Diagnostic Market Industry
4.2 Key Market Trends in Genetic Disease Diagnostic Market Industry
4.3 Potential Opportunities in Genetic Disease Diagnostic Market Industry
4.4 Key Challenges in Genetic Disease Diagnostic Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Genetic Disease Diagnostic Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Genetic Disease Diagnostic Market Outlook By Segments
7.1 Genetic Disease Diagnostic Market Outlook by Segments
By Applications
Inherited Disorder Testing
-Bloom Syndrome
-Gaucher’s Disease
-Tay-Sachs Disease
-Fragile X-Syndrome
-Others
PharmacoBy (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others

8 North America Genetic Disease Diagnostic Market Analysis And Outlook To 2030
8.1 Introduction to North America Genetic Disease Diagnostic Markets in 2024
8.2 North America Genetic Disease Diagnostic Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Genetic Disease Diagnostic Market size Outlook by Segments, 2021-2030
By Applications
Inherited Disorder Testing
-Bloom Syndrome
-Gaucher’s Disease
-Tay-Sachs Disease
-Fragile X-Syndrome
-Others
PharmacoBy (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others

9 Europe Genetic Disease Diagnostic Market Analysis And Outlook To 2030
9.1 Introduction to Europe Genetic Disease Diagnostic Markets in 2024
9.2 Europe Genetic Disease Diagnostic Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Genetic Disease Diagnostic Market Size Outlook By Segments, 2021-2030
By Applications
Inherited Disorder Testing
-Bloom Syndrome
-Gaucher’s Disease
-Tay-Sachs Disease
-Fragile X-Syndrome
-Others
PharmacoBy (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others

10 Asia Pacific Genetic Disease Diagnostic Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Genetic Disease Diagnostic Markets in 2024
10.2 Asia Pacific Genetic Disease Diagnostic Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Genetic Disease Diagnostic Market size Outlook by Segments, 2021-2030
By Applications
Inherited Disorder Testing
-Bloom Syndrome
-Gaucher’s Disease
-Tay-Sachs Disease
-Fragile X-Syndrome
-Others
PharmacoBy (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others

11 South America Genetic Disease Diagnostic Market Analysis And Outlook To 2030
11.1 Introduction to South America Genetic Disease Diagnostic Markets in 2024
11.2 South America Genetic Disease Diagnostic Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Genetic Disease Diagnostic Market size Outlook by Segments, 2021-2030
By Applications
Inherited Disorder Testing
-Bloom Syndrome
-Gaucher’s Disease
-Tay-Sachs Disease
-Fragile X-Syndrome
-Others
PharmacoBy (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others

12 Middle East And Africa Genetic Disease Diagnostic Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Genetic Disease Diagnostic Markets in 2024
12.2 Middle East and Africa Genetic Disease Diagnostic Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Genetic Disease Diagnostic Market size Outlook by Segments, 2021-2030
By Applications
Inherited Disorder Testing
-Bloom Syndrome
-Gaucher’s Disease
-Tay-Sachs Disease
-Fragile X-Syndrome
-Others
PharmacoBy (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Inc
Applied Biosystems Inc
AutoGenomics
BioRad Laboratories
Celera Group
Elitech Group
PerkinElmer Inc
Quest Diagnostics
Roche Diagnostics Corp
Transgenomic Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Applications
Inherited Disorder Testing
-Bloom Syndrome
-Gaucher’s Disease
-Tay-Sachs Disease
-Fragile X-Syndrome
-Others
PharmacoBy (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others